Aeon Astron

Home  Media Center  Exhibitions  » 2013 Intl Ophthalmology Congress
2013 Intl Ophthalmology Congress
2013 Annual Meeting of AAO, Nov 16-19, New Orleans, Booth 1855
Title: 2013 Annual Meeting of AAO, Nov 16-19, New Orleans, Booth 1855
Date: 2013-11-04
Join Aeon Astron at the 2013 Annual Meeting of the American Academy of Ophthalmology. Please visit our Booth 1855 at Morial Convention Center, New Orleans from Nov 16-19, 2013.

Since the first case report on the application of ologen Collagen Matrix for congenital glaucoma at SOE 2013 Congress, Copenhagen (by Dr. Hamdi M), more and more pediatric ophthalmology specialists are paying attention to the potential of the collagen matrix's wound healing effect in eye surgery, previously well-known in adult population and yet to be explored for pediatric ophthalmology. Following the presentation at 2013 WGC, Vancouver, Dr. Nigar Hasanova will present her comparative results at 2013 AAO, New Orleans, demonstrating that ologen CM is a safe and effective wound modulator in combined trabeculotomy-trabeculectomy (CTT) in the treatment of primary congenital glaucoma (PCG): 100% of the CTT cases with ologen CM showed IOP < 18 mmHg at the end of 6 months (mean preop IOP 40.4 ± 6.87 mmHg to postop IOP 13.6 ± 2.01 mmHg; n=10; P < .001) compared with 80% of the cases with CTT alone (mean preop IOP 41.0 ± 8.68 mmHg to postop IOP 16.3 ± 1.89 mmHg; n=10; P < .001). The video and follow-up will also be presented at the 2014 WOC Tokyo. We sincerely welcome your visit:

OP07 Pediatric Ophthalmology, Strabismus Original Paper Session:
Time: Nov 18 (Mon) 2:36PM - 2:43PM (the whole session 2-3PM)
Venue: Morial Convention Center Room: 255-257
Topic: PA054 Comparative Evaluation of Combined Trabeculotomy-Trabeculectomy vs. Combined Trabeculotomy-Trabeculectomy With Subconjunctival Implantation of Collagen Matrix Implant for Primary Congenital Glaucoma
Speaker: Nigar Hasanova-Makhmudova, MD

- Chair Terri L Young (Duke Eye Center)
- Hilda Capo (Bascom Palmer Eye Institute)
- Michael F Chiang (Oregon Health & Science Uni)
- Michelle T Cabrera (UNC)
Click here to link
2013 ESCRS Congress, Oct 05-08, Amsterdam, The Netherlands
Title: 2013 ESCRS Congress, Oct 05-08, Amsterdam, The Netherlands
Date: 2013-10-01
AAE will be attending the XXXI Congress of the European Society of Cataract & Refractive Surgeons (ESCRS) from Oct 05 - 08, 2013 at Amsterdam RAI, Europaplein, NL 1078 GZ, The Netherlands. Please visit our Booth B13.

At the meeting, ologen Collagen Matrix will feature as a useful tool in the "Eye Surgeon's Tool Box". From filtering surgery to combined cataract and glaucoma surgery, alone or in combination with MMC/Avastin, as a collagen patch to prevent tube exposure or to repair bleb leak, for wound modulation in pterygium excision and strabismus surgery, ologen Collagen Matrix is a solution to ophthalmic surgery you cannot do without.
2013 EVER meeting, Sept 18-21, Nice, France
Title: 2013 EVER meeting, Sept 18-21, Nice, France
Date: 2013-09-02
The 2013 EVER (European Vision and Eye Research) meeting will be held on September 18-21 at Acropolis Convention Center in Nice, France. Please attend the presentations of our current and under research products:

Sept 20 (Fri) 16:45-18:00 at "Hermes"
Free papers G 2/4: Glaucoma surgery part 1
17:21 Trabeculectomy revision surgery with Ologen biodegradable collagen matrix implant.
By Dr. PELOSINI L, Dr. ANSARI E – Maidstone, Kent, the UK

Sept 19 (Thu) 11:05-12:35 at "Rhodes 1"
Developments in corneal regeneration – NEXCR (Network of Excellence in Corneal Regeneration)
12:17 Suitability of a fish scale-derived collagen matrix (FSCM) as artificial cornea

(Full program at the NEXCR organized meeting can be found in the program book by clicking on the related link)
Click here to link
2013 World Glaucoma Congress, July 17-20, Vancouver
Title: 2013 World Glaucoma Congress, July 17-20, Vancouver
Date: 2013-06-28
As an industry member of the World Glaucoma Association, Aeon Astron will be exhibiting at the 2013 World Glaucoma Congress (WGC) in Vancouver. Please visit our Booth 204 at Vancouver Convention Centre, Canada, from July 18 - 20.

On the 18th of July (Thur), the new horizons of the novel applications for ologen Collagen Matrix will be unfolded in our early night symposium from 18:00 - 19:00 at Room 202 & 203. (Light snack and limited packed food will be provided.)

The symposium will cover the topics from the US experience with the collagen matrix (D Godfrey, USA), the combined/ supercharged Ex-Press ologen technique (S Vold, USA), an overview of the biosafe ologen patch graft in bleb revision surgery (R Fellman, USA), to the case reports and review of the anti-scarring solution applied in congenital glaucoma (N Hasanova, Azerbaijan) and non-penetrating deep sclerectomy NPDS (M Moussalli, Argentina).

If you will not be able join our event on the 18th night, please try to attend the WGC selected symposium on the 17th morning on the "Glaucoma Management Trend in Bangladesh" from 08:00 – 09:15 at room 210. (Chairs of the society's symposium: S. Maruf Ali, M. Nazrul Islam). Dr. S Noman will be sharing his experiences with more than 100 ologen CM trab cases in various kinds of primary & secondary glaucoma, including neovascular glaucoma, uveitic glaucoma, ICE syndrome, JOAG, angle recession glaucoma, microcornea etc.

We sincerely welcome your visit.
Click here to link
2013 ASCRS-ASOA Congress, Apr 20-23, San Francisco
Title: 2013 ASCRS-ASOA Congress, Apr 20-23, San Francisco
Date: 2013-03-27
2013 Annual ASCRS-ASOA Congress (American Society of Cataract & Refractive Surgery) will be held from 4/20 - 4/23 at Moscone Center, San Francisco (AAE booth number 2737). At the congress, our key message is:

“Empower your patient with a choice for healthier blebs”

Patients when receiving glaucoma surgery are often provided with insufficient information about the adjuvants used in the procedures, such as Mitomycin C (MMC) or the alternatives available to date. The barriers preventing optimal patient communication include cost concerns and poor accessibility to the newly established evidence of the alternatives, such as ologen Collagen Matrix.

While remaining common practice in some regions, the application of MMC may sometimes result in thin and avascular blebs: these blebs often require new revision surgery after some time. However, sacrificing a healthier bleb is not really necessary for the success of the glaucoma surgery. There are less- and non chemotoxic alternatives that may help obtain healthy and functional blebs.

To facilitate patient empowerment and communication, surgeons are advised to inform and actively involve their patients in the decision-making of the procedures and adjuvants to be received. Especially regarding the cosmetic effects, the short-term/long-term benefits and risks amid the adjunctive options and combinations, such as MMC, anti-VEGF (Bevacizumab, Pegaptanib) and ologen Collagen Matrix, as part of the evaluation process.

Visit our booth 2737 at ASCRS: for more information on how to empower your patient with a choice for healthier blebs.


Please also visit the presentation session on "Preliminary result of trabeculectomy with biodegradable implant in pseudophakic glaucoma with myopia".

Time & Venue: 8:07, 4/23; room 130
Author (speaker): Dr. Dipanjan Pal
Co-author: Dr. Jayangshu Sengupta
Click here to link
2013 Annual Meeting of the Dutch Oph Society, Mar 20-23, the Netherlands
Title: 2013 Annual Meeting of the Dutch Oph Society, Mar 20-23, the Netherlands
Date: 2013-03-07
2013 Annual Meeting of the Dutch Ophthalmological Society
Date & Venue: March 20 – 23, Groningen, the Netherlands

March 21, the first preliminary results of the Aeon Astron Europe B.V. initiated seeding trial entitled: “Trabeculectomy with ologen® Collagen matrix” will be presented by Dr. H.J.M. Beckers from the University Eye Clinic of the Maastricht University Medical Center. This trial, involving two leading Dutch glaucoma centers, the Maastricht University Medical Center and the Rotterdam Eye Hospital, and enrolling a total of 40 patients, is a prospective intervention pilot study to determine the degree of intraocular pressure lowering of trabeculectomy with ologen® Collagen matrix in comparison to trabeculectomy with the antimetabolite mitomycin-C (MMC). Additionally, the safety (per- and postoperative complications) of the two procedures will be compared. It will be the first report on the use of the ologen ®Collagen Matrix in the Netherlands.

De 207e vergadering van het Nederlands Oogheelkundig Gezelschap vindt plaats van woensdag 20 tot en met vrijdag 22 maart 2013 in Martiniplaza te Groningen.

Naast vrije voordrachten en posters komen er ’state of the art for all’ lezingen over pathologie en tumoren, orbita en adnexa en cornea, onderwerpen die terugkomen in het assistenten examen van 2013. Hiervoor worden prominente sprekers uitgenodigd, voor plenaire sessies van maximaal 30 minuten.
 (Extracted from
Click here to link
2013 Annual Meeting of AGS, Feb 28- Mar 2, San Francisco
Title: 2013 Annual Meeting of AGS, Feb 28- Mar 2, San Francisco
Date: 2013-02-08
Aeon Astron will be exhibiting at the 2013 Annual Meeting of the American Glaucoma Society (AGS). Please visit our Booth T24 at Marriott Marquis Hotel, San Francisco, from Feb 28 - Mar 2.

The meeting will be focusing on ologen Collagen Matrix's applications as synthetic patch graft for GDD / bleb revision/ tube revision surgery featuring:

- Ready-to-use: no rehydration required
- FREE from specific donor transmitted disease
- Pliable: superior patch graft functionality

With recommended CPT Codes, ologen Collagen Matrix may be an easier-to-use, safer, and more economic alternative to donor patch grafts. (Please contact AAE for CPT Code information.)
Click here to link
2013 APAO-AIOS Joint Congress, Jan 17-20, Hyderabad, India
Title: 2013 APAO-AIOS Joint Congress, Jan 17-20, Hyderabad, India
Date: 2012-12-21
At the 2013 Asia Pacific Academy of Ophthalmology Joint Congress with All India Ophthalmological Society - Aeon Astron will exhibit and hold a breakfast debate (ologen vs. MMC in glaucoma surgery) on Jan 18. Please visit our Booth H4-405 from Jan 17-20.

The use of ologen Collagen Matrix as an alternative to MMC is an art in glaucoma surgery; it concerns flexibility and suitability of the applications based on patient selection with corresponding surgical adjustments. The debate may touch on the issues involved, including:
- Less/looser scleral flap sutures with ologen CM
- Earlier sutures lysis/release with ologen CM
- Selection: secondary glaucoma, patients with history of failed surgery and risk factors (eg. thick Tenon's capsule)
- The combinative use of ologen CM with low-dose MMC in the difficult cases

Breakfast Debate Topic:
ologen® Collagen Matrix or Mitomycin-C for Glaucoma Surgery?

Time & Venue:
Jan-18-2013 (Friday), 07:30~08:15 am (2013 APAO-AIOS)
Hall 9, Hyderabad International Convention Centre, India
Breakfast served on a first-come, first-served basis
Special guest: Dr. R Ramakrishnan, Dr. SR Krishnadas
(Author/editor of "Diagnosis & Management of Glaucoma", Jaypee 2012)

Debate Moderator: Dr. Robert Ritch (Shelley and Steven Einhorn Distinguished Chair, New York Eye and Ear Infirmary)

ologen CM panelist:
- Dr B. Sridhar Rao (Su-Darshan Eye Clinic)
- Dr Sathyan Parthasarathy (Aravind Hospital)

MMC panelist:
- Dr Lingam Vijaya (Smt Jadhavabai Nathmal Singhvee Glaucoma Services)
- Dr Sirisha Senthil (L V Prasad Eye Institute)

Audience voting & QA Moderator: Dr. Robert Ritch
Click here to link
Copyright © Body Organ Biomedical Corp. All rights reserved.
Last updated on:2018-04-25